T W Ridky1, D Bizub-Bender, C E Cameron
1Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers engineered a Rous sarcoma virus protease (RSV PR) to mimic human immunodeficiency virus (HIV-1) PR. This modified RSV protease cleaves HIV-1 substrates and is inhibited by HIV-1 specific drugs, revealing key specificity determinants.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: